Last month, in Catania, Sicily, a 36-year-old man presented to the emergency room with complaints of high fever, sore throat, headache, weakness and inflammation in the groin area. In the tests performed at the hospital, it was determined that the patient was positive for Covid, monkeypox and HIV.
A FIRST IN THE LITERATURE!
The case, which is a first in the literature, was published in the Journal of Infection by researchers from the University of Catania Rodolico – San Marco and Palermo Giaccone Polyclinic.
IDENTITY KEPT CONFIDENTIAL
In the article titled ‘The first monkeypox virus, SARS-CoV-2 and HIV co-infection’, it was stated that the patient, whose identity was kept confidential, developed symptoms 9 days after vacationing in Spain on 16-22 June.
According to the article, the patient tested positive for Covid-19 on July 2, and had rashes on his left arm later that day; The next day, painful blisters began to form on the trunk, legs, face and buttocks.
It was also shared that the patient was treated for syphilis in 2019, the HIV test he had done in 2021 was negative, and he regularly took carbamazepine medication due to bipolar disorder.
According to the article, the man who had two doses of Covid vaccine last year, then had Covid 19 disease in January 2022.
Engaged in unprotected sexual intercourse
The patient said she had unprotected sex with men during her June trip to Spain.
In the article where the researchers evaluated these data, “Monkeypox virus and SARS-CoV-2 infections can be seen at the same time. Monkeypox is often diagnosed in people who have had a previous sexually transmitted infection.
It was stated that the patient was discharged after being treated in the hospital for about a week.
The article included the following statements:
“As this is the only reported case of monkeypox virus, SARS-CoV-2 and HIV co-infection, there is insufficient evidence to support that this combination can worsen the patient’s condition.
“Given the current SARS-CoV-2 pandemic and the daily increase in monkeypox cases, health systems should be aware of this possibility and promote appropriate diagnostic testing for control in high-risk cases.”
Praise Pinar | Rome